ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
Portfolio Pulse from
Rosen Law Firm is urging investors in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) who purchased securities between November 2, 2023, and October 30, 2024, to secure legal counsel before the March 10, 2025, lead plaintiff deadline in a securities class action.
February 22, 2025 | 2:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Rosen Law Firm is encouraging Regeneron Pharmaceuticals investors to join a securities class action before the March 10, 2025 deadline. This could impact REGN's stock price due to potential legal liabilities.
The involvement in a securities class action suggests potential legal liabilities for Regeneron, which could negatively impact investor sentiment and the stock price in the short term. The deadline for lead plaintiff is March 10, 2025, which is a critical date for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100